|
1
|
Wen PY, Macdonald DR, Reardon DA,
Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert
MR, Lassman AB, et al: Updated response assessment criteria for
high-grade gliomas: Response assessment in neuro-oncology working
group. J Clin Oncol. 28:1963–1972. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mittal S, Pradhan S and Srivastava T:
Recent advances in targeted therapy for glioblastoma. Expert Rev
Neurother. 15:935–946. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huse JT and Holland EC: Targeting brain
cancer: Advances in the molecular pathology of malignant glioma and
medulloblastoma. Nat Rev Cancer. 10:319–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seely BL, Staubs PA, Reichart DR, Berhanu
P, Milarski KL, Saltiel AR, Kusari J and Olefsky JM: Protein
tyrosine phosphatase 1B interacts with the activated insulin
receptor. Diabetes. 45:1379–1385. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lessard L, Stuible M and Tremblay ML: The
two faces of PTP1B in cancer. Biochim Biophys Acta. 1804:613–619.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cortesio CL, Chan KT, Perrin BJ, Burton
NO, Zhang S, Zhang ZY and Huttenlocher A: Calpain 2 and PTP1B
function in a novel pathway with Src to regulate invadopodia
dynamics and breast cancer cell invasion. J Cell Biol. 180:957–971.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H, Wu Y, Zhu S, Liang W, Wang Z, Wang
Y, Lv T, Yao Y, Yuan D and Song Y: PTP1B promotes cell
proliferation and metastasis through activating src and ERK1/2 in
non-small cell lung cancer. Cancer Lett. 359:218–225. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
LaMontagne KR Jr, Hannon G and Tonks NK:
Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced
transformation of rat-1 fibroblasts and promotes differentiation of
K562 cells. Proc NatI Acad Sci USA. 95:14094–14099. 1998.
View Article : Google Scholar
|
|
10
|
Balsamo J, Leung T, Ernst H, Zanin MK,
Hoffman S and Lilien J: Regulated binding of PTP1B-like phosphatase
to N-cadherin: Control of cadherin-mediated adhesion by
dephosphorylation of beta-catenin. J Cell Biol. 134:801–813. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen H, Chen W, Zhang X, Hu L, Tang G,
Kong J and Wang Z: E26 transformation (ETS)-specific related
transcription factor-3 (ELF3) orchestrates a positive feedback loop
that constitutively activates the MAPK/Erk pathway to drive thyroid
cancer. Oncol Rep. 41:570–578. 2019.PubMed/NCBI
|
|
12
|
Wu G, Mambo E, Guo Z, Hu S, Huang X,
Gollin SM, Trink B, Ladenson PW, Sidransky D and Xing M: Uncommon
mutation, but common amplifications of the PIK3CA gene in thyroid
tumors. J Clin Endocrinol Metab. 90:4688–4693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Engelman JA, Zejnullahu K, Mitsudomi T,
Song Y, Hyland C, Park JO, Lindeman N, Gale CM, Zhao X, Christensen
J, et al: MET amplification leads to gefitinib resistance in lung
cancer by activating ERBB3 signaling. Science. 316:1039–1043. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawano O, Sasaki H, Okuda K, Yukiue H,
Yokoyama T, Yano M and Fujii Y: PIK3CA gene amplification in
Japanese non-small cell lung cancer. Lung Cancer. 58:159–160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mambo E, Gao X, Cohen Y, Guo Z, Talalay P
and Sidransky D: Electrophile and oxidant damage of mitochondrial
DNA leading to rapid evolution of homoplasmic mutations. Proce Natl
Acad Sci USA. 100:1838–1843. 2003. View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guha A, Feldkamp MM, Lau N, Boss G and
Pawson A: Proliferation of human malignant astrocytomas is
dependent on Ras activation. Oncogene. 15:2755–2765. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Annibali D, Whitfield JR, Favuzzi E,
Jauset T, Serrano E, Cuartas I, Redondo-Campos S, Folch G,
Gonzàlez-Juncà A, Sodir NM, et al: Myc inhibition is effective
against glioma and reveals a role for Myc in proficient mitosis.
Nat Commun. 5:46322014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tu M, Wange W, Cai L, Zhu P, Gao Z and
Zheng W: IL-13 receptor alpha2 stimulates human glioma cell growth
and metastasis through the Src/PI3K/Akt/mTOR signaling pathway.
Tumour Biol. 37:14701–14709. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Chen T, Zhang J, Mao Q, Li S,
Xiong W, Qiu Y, Xie Q and Ge J: Notch1 promotes glioma cell
migration and invasion by stimulating beta-catenin and NF-kappaB
signaling via AKT activation. Cancer Sci. 103:181–190. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taliaferro-Smith L, Nagalingam A, Knight
BB, Oberlick E, Saxena NK and Sharma D: Integral role of PTP1B in
adiponectin-mediated inhibition of oncogenic actions of leptin in
breast carcinogenesis. Neoplasia. 15:23–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Liu B, Chen X, Su L, Wu P, Wu J
and Zhu Z: PTP1B expression contributes to gastric cancer
progression. Med Oncol. 29:948–956. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reichardt W, Jung V, Brunner C, Klein A,
Wemmert S, Romeike BF, Zang KD and Urbschat S: The putative
serine/threonine kinase gene STK15 on chromosome 20q13.2 is
amplified in human gliomas. Oncol Rep. 10:1275–1279.
2003.PubMed/NCBI
|
|
26
|
Mondol AS, Tonks NK and Kamata T: Nox4
redox regulation of PTP1B contributes to the proliferation and
migration of glioblastoma cells by modulating tyrosine
phosphorylation of coronin-1C. Free Radic Biol Med. 67:285–291.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akasaki Y, Liu G, Matundan HH, Ng H, Yuan
X, Zeng Z, Black KL and Yu JS: A peroxisome proliferator-activated
receptor-gamma agonist, troglitazone, facilitates caspase-8 and −9
activities by increasing the enzymatic activity of protein-tyrosine
phosphatase-1B on human glioma cells. J Biol Chem. 281:6165–6174.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Petri MK, Koch P, Stenzinger A,
Kuchelmeister K, Nestler U, Paradowska A, Steger K, Brobeil A,
Viard M and Wimmer M: PTPIP51, a positive modulator of the MAPK/Erk
pathway, is upregulated in glioblastoma and interacts with 14–3-3β
and PTP1B in situ. Histol Histopathol. 26:1531–1543.
2011.PubMed/NCBI
|
|
29
|
Zhu S, Bjorge JD and Fujita DJ: PTP1B
contributes to the oncogenic properties of colon cancer cells
through Src activation. Cancer Res. 67:10129–10137. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen T, George JA and Taylor CC: Src
tyrosine kinase as a chemotherapeutic target: Is there a clinical
case? Anticancer Drugs. 17:123–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Zhang Z, Li R, Mao F, Sun W, Chen
J, Zhang H, Bartsch JW, Shu K and Lei T: ADAM12 induces EMT and
promotes cell migration, invasion and proliferation in pituitary
adenomas via EGFR/ERK signaling pathway. Biomed Pharmacother.
97:1066–1077. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Du MR, Zhou WH, Yan FT, Zhu XY, He YY,
Yang JY and Li DJ: Cyclosporine A induces titin expression via
MAPK/ERK signalling and improves proliferative and invasive
potential of human trophoblast cells. Hum Reprod. 22:2528–2537.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang HY, Chang HF, Tsai MJ, Chen JS and
Wang MJ: 6-Mercaptopurine attenuates tumor necrosis factor-alpha
production in microglia through Nur77-mediated transrepression and
PI3K/Akt/mTOR signaling-mediated translational regulation. J
Neuroinflammation. 13:782016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Butowski NA and Chang SM: Glial tumors:
The current state of scientific knowledge. Clin Neurosurg.
53:106–113. 2006.PubMed/NCBI
|
|
35
|
Purow BW, Sundaresan TK, Burdick MJ, Kefas
BA, Comeau LD, Hawkinson MP, Su Q, Kotliarov Y, Lee J, Zhang W and
Fine HA: Notch-1 regulates transcription of the epidermal growth
factor receptor through p53. Carcinogenesis. 29:918–925. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo G, Yao W, Zhang Q and Bo Y: Oleanolic
acid suppresses migration and invasion of malignant glioma cells by
inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hollander MC, Blumenthal GM and Dennis PA:
PTEN loss in the continuum of common cancers, rare syndromes and
mouse models. Nat Rev Cancer. 11:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pao W and Girard N: New driver mutations
in non-small-cell lung cancer. Lancet Oncol. 12:175–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chai C, Song LJ, Han SY, Li XQ and Li M:
MicroRNA-21 promotes glioma cell proliferation and inhibits
senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT
signaling pathway. CNS Neurosci Ther. 24:369–380. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang L, Wang Z, Liu C, Gong Z, Yang Y,
Kang H, Li Y and Hu G: TrkB promotes laryngeal cancer metastasis
via activation PI3K/AKT pathway. Oncotarget. 8:108726–108737. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ceccarelli M, Barthel FP, Malta TM,
Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh
A, Pagnotta SM, et al: Molecular profiling reveals biologically
discrete subsets and pathways of progression in diffuse glioma.
Cell. 164:550–563. 2016. View Article : Google Scholar : PubMed/NCBI
|
